EPANOVA in Crohn's Disease, Study 1

NCT00613197 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
384
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tillotts Pharma AG